5 Results

People

  1. Comenzo
    Comenzo
  2. Hassoun
    Hassoun
  3. Kewalramani
    Kewalramani
  4. Nimer
    Nimer
  5. Reich
    Reich
  6. Fleisher
    Fleisher
  7. Klimek
    Klimek
  8. Cohen
    Cohen
  9. Dhodapkar
    Dhodapkar
  10. Feldstein
    Feldstein

Groups

  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Myeloma (5)
  5. Adult Leukemia (4)
  6. Division of Subspecialty Medicine (1)
  7. Nursing (1)
  8. Renal (1)
  9. Survivorship Research (1)
  1. "dexamethasone"
  2. "Hani Hassoun"
  3. "Lilian Reich"
Formats
  1. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Myeloma (5)
  5. Adult Leukemia (4)
  6. Division of Subspecialty Medicine (1)

More Groups

People
  1. Hani Hassoun (5)
  2. Lilian Reich (5)
  3. Raymond Comenzo (5)
  4. Stephen Nimer (5)
  5. Tarun Kewalramani (5)
  6. Daniel Filippa (4)

More People

Years
  1. 2008 (1)
  2. 2007 (1)
  3. 2006 (2)
  4. 2005 (1)
Publications
  1. Bone Marrow Transplantation (2)
  2. British Journal of Haematology (2)
  3. Leukemia (1)
Publishers
  1. Nature Publishing Group (3)
  2. John Wiley & Sons (2)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease
    Journal Article

    Hassoun, H.; Flombaum, C.; D'Agati, V. D.; Rafferty, B. T.; Cohen, A.; Klimek, V. M.; Boruchov, A.; Kewalramani, T.; Reich, L.; Nimer, S. D.; more...
    Bone Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: Results of a phase II trial
    Journal Article

    Cohen, A. D.; Zhou, P.; Chou, J.; Teruya-Feldstein, J.; Reich, L.; Hassoun, H.; Levine, B.; Filippa, D. A.; Riedel, E.; Kewalramani, T.; more...
    British Journal of Haematology (2007)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
    Journal Article

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation
    Journal Article

    Comenzo, R. L.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Dhodapkar, M.; Reich, L.; Teruya-Feldstein, J.; Fleisher, M.; Filippa, D.; Nimer, S. D.
    Leukemia (2006)

    Fulltext@MSK | Save
  • Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
    Journal Article

    Gupta, S.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Reich, L.; Costello, S.; Drake, L.; Klimek, V.; Dhodapkar, M.; Teruya-Feldstein, J.; more...
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save